Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

TB-500 UK 2026: Complete Research Reference | Peptides Lab UK

Important regulatory notice. TB-500 is not licensed by the MHRA for human or veterinary use in the United Kingdom. It is supplied to the laboratory market as

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

TB-500 UK 2026: Complete Research Reference | Peptides Lab UK

Important regulatory notice. TB-500 is not licensed by the MHRA for human or veterinary use in the United Kingdom. It is supplied to the laboratory market as a research-use-only reference compound and appears on the WADA Prohibited List in sport. This page is a literature-context overview and trust-signal sourcing reference. It is not personal-use guidance and Peptides Lab UK does not endorse any human or veterinary use of TB-500.

Quick reference summary. TB-500 is a synthetic peptide containing an active fragment from thymosin beta-4 (TB4), a naturally occurring protein implicated in cellular migration, actin biology and angiogenesis in the published cell-biology literature. The published TB-500 research is dominated by in-vitro and small-animal model work. TB-500 is on the WADA Prohibited List and is not licensed in any major jurisdiction. Peptides Lab UK supplies TB-500 as a research-use-only laboratory reference compound with batch-specific HPLC certificates of analysis.

UK regulatory and sport-testing position (2026)

TB-500 has no UK marketing authorisation. The MHRA opened investigations in April 2026 into UK clinics making therapeutic claims about unregulated peptide products. TB-500 is also banned in WADA-accredited anti-doping testing under the peptide hormones, growth factors, related substances and mimetics class. WADA-accredited laboratories run targeted assays for TB-500. Anyone competing under WADA, UK Anti-Doping (UKAD), professional federation rules or military testing should treat TB-500 as a detectable banned substance.

What the molecule actually is

TB-500 is a synthetic peptide that contains an active sequence from thymosin beta-4. Thymosin beta-4 is a naturally occurring 43-amino-acid protein found in most mammalian cells. The published cell-biology literature describes TB4 in the context of cellular migration, actin polymerisation regulation, and angiogenesis-related gene expression.

What the published research record covers

The peer-reviewed TB-500 and TB4 literature is dominated by in-vitro cell-culture studies of cellular migration, actin biology and signal transduction, plus rodent-model studies of soft-tissue repair (tendon, ligament) and cardiac models of myocardial injury. Large blinded placebo-controlled human clinical trials of TB-500 are not available, and TB-500 has not been advanced through the regulated drug-development pathway by any pharmaceutical sponsor.

Quality requirements for a research-grade reference sample

For laboratory researchers, identity and purity are the only metrics that matter. A responsible supplier publishes:

Batch-specific certificate of analysis (COA), downloadable per batch

Third-party HPLC purity data with chromatogram

Mass-spectrometry identity confirmation against the TB-500 reference standard

Clear research-use-only labelling, with no human or veterinary use claim

Stability and storage data for the supplied batch

Peptides Lab UK supplies TB-500 on this basis. View our research-grade TB-500 listing for batch documentation, packaging and pricing.

How to evaluate any UK TB-500 supplier

Five questions to ask any UK supplier before placing a research-grade order. (1) Does each batch ship with a third-party HPLC COA? (2) Is mass-spectrometry identity confirmation available? (3) Is the labelling research-use-only with no human-use claims? (4) Is the supplier transparent about source manufacturing and storage chain? (5) Does the supplier publish stability data for the supplied batch? Any ‘no’ or vague answer is a red flag in the current UK enforcement environment.

For laboratory researchers

If you are working in cell migration biology, actin chemistry, angiogenesis, or small-animal soft-tissue or cardiac repair models, TB-500 is a research reference compound with a substantial cell-biology and rodent-model publication trail. The primary literature is indexed on PubMed. For a research-grade reference sample with batch-specific HPLC and COA documentation, see the TB-500 product listing.

Frequently Asked Questions

Is TB-500 licensed in the UK?

No. TB-500 has not received MHRA, EMA or FDA marketing authorisation.

Is TB-500 banned in sport?

Yes. TB-500 is on the WADA Prohibited List and WADA-accredited laboratories run targeted assays for it.

What does the published research record cover?

In-vitro cell-biology of actin and migration, plus rodent-model soft-tissue and cardiac repair studies. Published large human clinical-trial data is not available.

What should a research-grade TB-500 reference sample come with?

Batch-specific COA, third-party HPLC purity data, mass-spectrometry identity confirmation, clear research-use-only labelling, and stability documentation.

Where can I read the source literature?

The peer-reviewed thymosin beta-4 and TB-500 literature is indexed on PubMed.

Research use only. Peptides Lab UK supplies research-use-only laboratory reference compounds with batch-specific certificates of analysis. Products are not for human or veterinary use. TB-500 is also banned in sport under the WADA Prohibited List.

William is a research analyst at Peptides Lab UK, specialising in research peptides, laboratory compounds, and sourcing standards for high-purity peptide products.

You May Also Like

Connected topics

Follow this recovery question